Douglas Lane & Associates’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
NC
Douglas Lane & Associates's SNPS Position: Q2 2026 in Review
Douglas Lane & Associates increased its Synopsys (SNPS) stake by 28% in Q2 2026, buying an estimated $8.16M and bringing the position to 79,872 shares worth $35.6M. The position accounts for 0.48% of the portfolio, ranked #79.
Douglas Lane & Associates first reported a position in SNPS in Q3 2025 and has held it in 4 quarters since. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.
- Douglas Lane & Associates held 79,872 shares of Synopsys worth $35.6M as of Q2 2026.
- Douglas Lane & Associates bought 17,362 Synopsys shares in Q2 2026, an estimated $8.16M.
- Synopsys made up 0.48% of Douglas Lane & Associates's portfolio in Q2 2026, its #79 holding.
- Douglas Lane & Associates first reported a position in Synopsys in Q3 2025 and has held it in 4 quarters since.
- 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.
Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.